Johns Hopkins, Yale, and NYU are teaming up to tackle a key bottleneck that will arise as psychedelics come to market

As psychedelics treatments move closer to regulatory approval, there’s an issue looming in the industry: the lack of trained professionals who can handle such powerful compounds. Johns Hopkins, Yale University, and New York University have announced they are collaborating to create a psychedelics curriculum for psychiatrists. A $1 million grant will fund researchers at the three schools over the next two years to develop a curriculum for psychiatrists and create educational materials for other medical professionals.